---
figid: PMC5329966__12967_2017_1152_Fig3_HTML
figlink: /pmc/articles/PMC5329966/figure/Fig3/
number: Fig. 3
caption: Heterogeneous responses of normal and malignant B cells upon CpG ODNs stimulation.
  Activation of TLR9 results in the recruitment of MyD88 to initiate the activation
  of NF-κB, JNK, and p38 MAPK signaling pathways. Arrows represent activation. Bars
  represent inhibition. Activation of the NF-κB signaling pathway exerts both antiapoptotic
  and proapoptotic effects. In normal B cells (black lines), activation of NF-κB upregulates
  the expression of BCL-XL, which blocks cytochrome c release and protects B cells
  from apoptosis. However, upon treatment of the mouse B-cell lymphoma cell line CH27
  with CpG ODNs, overexpression of c-Myc results in transient activation of NF-κB
  and subsequent inhibition of NF-κB activation (red bar). And then, c-Myc promotes
  tumor necrosis factor-induced apoptosis by decreasing BCL-XL expression and increasing
  FAS expression. In MM cells (purple lines), NF-κB is involved in the activation
  of Ras-dependent MAPK cascades and the JAK/STAT3 signaling pathway, which is associated
  with the proliferation of processed IL-6. In B-CLL cells (blue lines), activation
  of the NF-κB signaling pathway induces autocrine IL-10 secretion, which further
  induces phosphorylation and activation of the signal transducer and activator of
  transcription 1, resulting in the cleavage and activation of caspases as well as
  the subsequent apoptosis of B-CLL cells (MyD88 myeloid differentiation antigen 88,
  IFN interferon, CLL chronic lymphocytic leukemia, MM multiple myeloma, MAPK mitogen-activated
  protein kinases, PI3K phosphatidylinositol 3-kinase, DR5 death receptor 5, TRAIL
  TNF-related apoptosis-inducing ligand, STAT1 signal transducer and activator of
  transcription 1)
pmcid: PMC5329966
papertitle: Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies
  and its potential therapeutic application.
reftext: Ling Bai, et al. J Transl Med. 2017;15:51.
pmc_ranked_result_index: '105968'
pathway_score: 0.9657525
filename: 12967_2017_1152_Fig3_HTML.jpg
figtitle: Heterogeneous responses of normal and malignant B cells upon CpG ODNs stimulation
year: '2017'
organisms: Homo sapiens
ndex: 2301a621-dec7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5329966__12967_2017_1152_Fig3_HTML.html
  '@type': Dataset
  description: Heterogeneous responses of normal and malignant B cells upon CpG ODNs
    stimulation. Activation of TLR9 results in the recruitment of MyD88 to initiate
    the activation of NF-κB, JNK, and p38 MAPK signaling pathways. Arrows represent
    activation. Bars represent inhibition. Activation of the NF-κB signaling pathway
    exerts both antiapoptotic and proapoptotic effects. In normal B cells (black lines),
    activation of NF-κB upregulates the expression of BCL-XL, which blocks cytochrome
    c release and protects B cells from apoptosis. However, upon treatment of the
    mouse B-cell lymphoma cell line CH27 with CpG ODNs, overexpression of c-Myc results
    in transient activation of NF-κB and subsequent inhibition of NF-κB activation
    (red bar). And then, c-Myc promotes tumor necrosis factor-induced apoptosis by
    decreasing BCL-XL expression and increasing FAS expression. In MM cells (purple
    lines), NF-κB is involved in the activation of Ras-dependent MAPK cascades and
    the JAK/STAT3 signaling pathway, which is associated with the proliferation of
    processed IL-6. In B-CLL cells (blue lines), activation of the NF-κB signaling
    pathway induces autocrine IL-10 secretion, which further induces phosphorylation
    and activation of the signal transducer and activator of transcription 1, resulting
    in the cleavage and activation of caspases as well as the subsequent apoptosis
    of B-CLL cells (MyD88 myeloid differentiation antigen 88, IFN interferon, CLL
    chronic lymphocytic leukemia, MM multiple myeloma, MAPK mitogen-activated protein
    kinases, PI3K phosphatidylinositol 3-kinase, DR5 death receptor 5, TRAIL TNF-related
    apoptosis-inducing ligand, STAT1 signal transducer and activator of transcription
    1)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOSL2
  - CASP5
  - CASP4
  - IL12A
  - FOSB
  - IL10RA
  - MAPK1
  - MAPK3
  - IL10
  - CASP3
  - JUNB
  - JUND
  - FAS
  - IFNA1
  - MYC
  - FOS
  - IL12B
  - TYK2
  - JUN
  - CASP6
  - JAK3
  - FOSL1
  - BAX
  - IL6
  - CASP7
  - CASP1
  - CASP2
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK12
  - MYD88
  - BCL2L1
  - MAPK8
  - CD86
  - CASP12
  - CASP14
  - MAPK13
  - TLR9
  - TNF
  - TRAF6
  - IRAK1
  - NFKB1
  - MAPK14
  - NRAS
  - IRAK4
  - IL6R
  - JAK1
  - JAK2
  - NR2C2
  - HRAS
  - CASP8
  - CASP9
  - CD80
  - STAT1
  - KRAS
  - CASP10
  - Cancer
genes:
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: IL-10R
  symbol: IL10R
  source: hgnc_prev_symbol
  hgnc_symbol: IL10RA
  entrez: '3587'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: C-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: IL-12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: JAK/STATS
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: JAK/STATS
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: BAX
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: BCL-XL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: JŅK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JŅK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JŅK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RÁS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: JAK/STATS
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STATS
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: RÁS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: STAT-1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: RÁS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
